Recommended reconstitution volumes: For a 50mg vial, add 2.0mL BAC water (resulting concentration: 25mg/mL)
PMC 6073405
Evidence is weaker than minoxidil / finasteride , so we always use it as an add-on , not a replacement
A randomized, controlled, blinded human trial of GHK-Cu monotherapy, with a vehicle-only control (and a needling-plus-vehicle arm if a procedure is used), objective endpoints such as blinded global photography and target-area hair counts over at least several months, adequate statistical power, pre-registration, and independent replication
Cycle Length Reference Charts Cycling GHK-CU helps maintain receptor sensitivity and prevents potential copper accumulation
CDC injection-safety guidance On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1